Genetic Leap
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1740 Broadway Fl 15, New York City, New ...Website
www.genetic-leap.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Genetic Leap
Genetic Leap is a clinical stage biotech company that leverages AI and RNA genetic medicine to revolutionize drug development and address health needs efficiently. Their AI platform effectively targets RNA at both the sequence and structural levels using oligonucleotides and small molecules. The company aims to enhance RNA-targeted genetic medicine development and small molecule design through innovative partnerships and collaborations. Their primary clients include healthcare providers and researchers focused on advancing genetic therapies.Explore more
Genetic Leap Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genetic Leap your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Genetic Leap, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Genetic Leap recently announced quarterly report
Product Launch: Get notified when Genetic Leap launches new products
Click to see if Genetic Leap had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Genetic Leap is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Genetic Leap
Check if Genetic Leap has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Genetic Leap has new funding data
Recommended Actions
Find VP level buyers at Genetic Leap
Find more new buyers
Compare Similar Companies to Genetic Leap
Compare insights from companies similar to Genetic Leap, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Genetic Leap is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Genetic Leap is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Genetic Leap.
Genetic Leap Tech Stack
Genetic Leap News & Media
Eli Lilly signs a $409 million research deal with AI-powered drug discovery startup Genetic Leap
Global pharmaceutical leader Eli Lilly has struck a research agreement with AI-driven drug discovery startup Genetic Leap. The deal is worth $409 million, according to an announcement by Genetic Leap on Thursday. As part of the deal, Genetic Leap will […] The post Eli Lilly signs a $409 million research deal with AI-powered drug discovery startup Genetic Leap first appeared on Tech Startups.Genetic Leap and Lilly Enter Collaboration to Accelerate Genetic Medicine Development with AI
-- Collaboration to leverage Genetic Leap's RNA-targeted AI platform to generate genetic medicines against selected targets -- Genetic Leap to receive up to $409 million in upfront and milestone payments as well as tiered royalties NEW YORK, Sept. 5, 2024 /PRNewswire/ -- Genetic Leap, an...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genetic Leap
Sign Up For FreeTo access detailed company insights
Genetic Leap is a clinical stage biotech company that leverages AI and RNA genetic medicine to revolutionize drug development and address health needs efficiently. Their AI platform effectively targets RNA at both the sequence and structural levels using oligonucleotides and small molecules. The company aims to enhance RNA-targeted genetic medicine... Read More
